-DOCSTART- -X- O
Worldwide -X- _ O
, -X- _ O
suicide -X- _ B-Patient
is -X- _ O
a -X- _ O
leading -X- _ O
cause -X- _ O
of -X- _ O
death. -X- _ O
Although -X- _ O
a -X- _ O
sizable -X- _ O
proportion -X- _ O
of -X- _ O
deaths -X- _ O
by -X- _ O
suicide -X- _ B-Patient
may -X- _ O
be -X- _ O
preventable -X- _ O
, -X- _ O
it -X- _ O
is -X- _ O
well -X- _ O
documented -X- _ O
that -X- _ O
despite -X- _ O
major -X- _ O
governmental -X- _ O
and -X- _ O
international -X- _ O
investments -X- _ O
in -X- _ O
research -X- _ O
, -X- _ O
education -X- _ O
and -X- _ O
clinical -X- _ O
practice -X- _ O
suicide -X- _ O
rates -X- _ O
have -X- _ O
not -X- _ O
diminished -X- _ O
and -X- _ O
are -X- _ O
even -X- _ O
increasing -X- _ O
among -X- _ O
several -X- _ O
at-risk -X- _ O
populations. -X- _ O
Although -X- _ O
nonhuman -X- _ O
animals -X- _ O
do -X- _ O
not -X- _ O
engage -X- _ O
in -X- _ O
suicidal -X- _ O
behavior -X- _ O
amenable -X- _ O
to -X- _ O
translational -X- _ O
studies -X- _ O
, -X- _ O
we -X- _ O
argue -X- _ O
that -X- _ O
animal -X- _ O
model -X- _ O
systems -X- _ O
are -X- _ O
necessary -X- _ O
to -X- _ O
investigate -X- _ O
candidate -X- _ O
endophenotypes -X- _ O
of -X- _ O
suicidal -X- _ O
behavior -X- _ O
and -X- _ O
the -X- _ O
neurobiology -X- _ O
underlying -X- _ O
these -X- _ O
endophenotypes. -X- _ O
Animal -X- _ O
models -X- _ O
are -X- _ O
similarly -X- _ O
a -X- _ O
critical -X- _ O
resource -X- _ O
to -X- _ O
help -X- _ O
delineate -X- _ O
treatment -X- _ O
targets -X- _ O
and -X- _ O
pharmacological -X- _ O
means -X- _ O
to -X- _ O
improve -X- _ O
our -X- _ O
ability -X- _ O
to -X- _ O
manage -X- _ O
the -X- _ O
risk -X- _ O
of -X- _ O
suicide. -X- _ B-Patient
In -X- _ O
particular -X- _ O
, -X- _ O
certain -X- _ O
pathophysiological -X- _ O
pathways -X- _ O
to -X- _ O
suicidal -X- _ O
behavior -X- _ O
, -X- _ O
including -X- _ O
stress -X- _ O
and -X- _ O
hypothalamic–pituitary–adrenal -X- _ O
axis -X- _ O
dysfunction -X- _ O
, -X- _ O
neurotransmitter -X- _ O
system -X- _ O
abnormalities -X- _ O
, -X- _ O
endocrine -X- _ O
and -X- _ O
neuroimmune -X- _ O
changes -X- _ O
, -X- _ O
aggression -X- _ O
, -X- _ O
impulsivity -X- _ O
and -X- _ O
decision-making -X- _ O
deficits -X- _ O
, -X- _ O
as -X- _ O
well -X- _ O
as -X- _ O
the -X- _ O
role -X- _ O
of -X- _ O
critical -X- _ O
interactions -X- _ O
between -X- _ O
genetic -X- _ O
and -X- _ O
epigenetic -X- _ O
factors -X- _ O
, -X- _ O
development -X- _ O
and -X- _ O
environmental -X- _ O
risk -X- _ O
factors -X- _ O
can -X- _ O
be -X- _ O
modeled -X- _ O
in -X- _ O
laboratory -X- _ O
animals. -X- _ O
We -X- _ O
broadly -X- _ O
describe -X- _ O
human -X- _ O
biological -X- _ O
findings -X- _ O
, -X- _ O
as -X- _ O
well -X- _ O
as -X- _ O
protective -X- _ O
effects -X- _ O
of -X- _ O
medications -X- _ B-Intervention
such -X- _ I-Intervention
as -X- _ I-Intervention
lithium -X- _ I-Intervention
, -X- _ I-Intervention
clozapine -X- _ I-Intervention
, -X- _ I-Intervention
and -X- _ I-Intervention
ketamine -X- _ I-Intervention
associated -X- _ O
with -X- _ O
modifying -X- _ O
risk -X- _ O
of -X- _ O
engaging -X- _ O
in -X- _ O
suicidal -X- _ O
behavior -X- _ O
that -X- _ O
are -X- _ O
readily -X- _ O
translatable -X- _ O
to -X- _ O
animal -X- _ O
models. -X- _ O
Endophenotypes -X- _ B-Outcome
of -X- _ I-Outcome
suicidal -X- _ I-Outcome
behavior -X- _ I-Outcome
, -X- _ I-Outcome
studied -X- _ I-Outcome
in -X- _ I-Outcome
animal -X- _ I-Outcome
models -X- _ I-Outcome
, -X- _ I-Outcome
are -X- _ I-Outcome
further -X- _ I-Outcome
useful -X- _ I-Outcome
for -X- _ I-Outcome
moving -X- _ I-Outcome
observed -X- _ I-Outcome
associations -X- _ I-Outcome
with -X- _ I-Outcome
harmful -X- _ I-Outcome
environmental -X- _ I-Outcome
factors -X- _ I-Outcome
( -X- _ I-Outcome
for -X- _ I-Outcome
example -X- _ I-Outcome
, -X- _ I-Outcome
childhood -X- _ I-Outcome
adversity -X- _ I-Outcome
, -X- _ I-Outcome
mechanical -X- _ I-Outcome
trauma -X- _ I-Outcome
aeroallergens -X- _ I-Outcome
, -X- _ I-Outcome
pathogens -X- _ I-Outcome
, -X- _ I-Outcome
inflammation -X- _ I-Outcome
triggers -X- _ I-Outcome
) -X- _ I-Outcome
from -X- _ I-Outcome
association -X- _ I-Outcome
to -X- _ I-Outcome
causation -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
developing -X- _ I-Outcome
preventative -X- _ I-Outcome
strategies. -X- _ I-Outcome
Further -X- _ O
study -X- _ O
in -X- _ O
animals -X- _ O
will -X- _ O
contribute -X- _ O
to -X- _ O
a -X- _ O
more -X- _ O
informed -X- _ O
, -X- _ O
comprehensive -X- _ O
, -X- _ O
accelerated -X- _ O
and -X- _ O
ultimately -X- _ O
impactful -X- _ O
suicide -X- _ B-Patient
research -X- _ O
portfolio -X- _ O
. -X- _ O

